Company intelligence / Profile preview
Nirvana Life Sciences
Vancouver, British Columbia, Canadanirvanalifescience.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has psilocybin-based compounds in preclinical development for opioid addiction and non-addictive pain management. Preclinical research is being conducted at the University of Camerino in Italy with special government permission to work with psilocybin compounds.
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
University of Camerino
Beyond the preview
Go deeper on Nirvana Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nirvana Life Sciences.